Electra banks $183m for sHLH drug, and other biofinancings
Electra Therapeutics Secures $183m for sHLH Drug Electra Therapeutics has raised $183 million in a Series C financing round to support its phase 2/3 trial of ELA026, a potential therapy fo…
Electra Therapeutics Secures $183m for sHLH Drug Electra Therapeutics has raised $183 million in a Series C financing round to support its phase 2/3 trial of ELA026, a potential therapy fo…
Reactions to Columbus Day from Native American Day Participants Despite the national holiday being changed to Columbus Day by President Tr…
Apple Stock Boosts Dow After Strong iPhone Sales Apple stock (AAPL) is leading the Dow today, up 4.3% to $263.18, following positive iPhon…
Call for Action to Boost Solomon Islands' Industrial Growth According to local economist Martin Hou, Solomon Islands continues to face sig…
High Wind Warning Issued for Our Area A Wind Advisory has been issued for our area by NOAA, effective from tonight to Wednesday, with gust…
Concerns Over Unequal NHS Access to Weight-Loss Drugs in Scotland Poverty campaigners warn that access to NHS weight-loss medications in …